Clinics in Dermatology
Volume 27, Issue 1 , Pages 122-133 , January 2009

Ocular melanoma: relatively rare but requiring respect

References 

  1. Shields JA, Shields CL. In: Atlas of intraocular tumors. Philadelphia: Lippincott Williams and Wilkins; 1999;p. 74–150
  2. Shields JA, Shields CL. In: Intraocular tumors: a text and atlas. Philadelphia: WB Saunders; 1992;p. 117–206
  3. Yu GP, Hu DN, McCormick S, Finger PT. Conjunctival melanoma: is it increasing in the United States?. Am J Ophthalmol. 2003;135:800–806
  4. Chan FM, O'Donnell BA, Whitehead K, et al. Treatment and outcomes of malignant melanoma of the eyelid: a review of 29 cases in Australia. Ophthalmology. 2007;114:187–192
  5. Shields JA, Shields CL. Orbital malignant melanoma. The 2002 Sean B. Murphy Lecture. Ophthal Plast Reconstr Surg. 2003;19:62–69
  6. Shields CL, Shields JA, Gross N, et al. Survey of 520 eyes with uveal metastases. Ophthalmology. 1997;104:1265–1276
  7. de Bustros S, Augsburger JJ, Shields JA, et al. Intraocular metastases from cutaneous malignant melanoma. Arch Ophthalmol. 1985;103:937–940
  8. Shields CL, Shields JA, Materin M, et al. Iris melanoma: risk factors for metastasis in 169 consecutive patients. Ophthalmology. 2001;108:172–178
  9. Li W, Judge H, Gragoudas ES, et al. Patterns of tumor initiation in choroidal melanoma. Cancer Res. 2000;60:3757–3760
  10. Singh AD, De Potter P, Fijal BA, et al. Lifetime prevalence of uveal melanoma in white patients with oculo(dermal) melanocytosis. Ophthalmology. 1998;105:195–198
  11. Sumich P, Mitchell P, Wang JJ. Choroidal nevi in a white population: The Blue Mountains Eye Study. Arch Ophthalmol. 1998;116:645–650
  12. Ganley JP, Comstock GW. Benign nevi and malignant melanomas of the choroid. Am J Ophthalmol. 1973;76:19–25
  13. Singh AD, Kalyani P, Topham A. Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology. 2005;112:1784–1789
  14. Shields CL, Shields JA, Kiratli H, et al. Risk factors for growth and metastasis of small choroidal melanocytic lesions. Ophthalmology. 1995;102:1351–1361
  15. Shields CL, Cater J, Shields JA, et al. Combination of clinical factors predictive of growth of small choroidal melanomcytic tumors. Arch Ophthalmol. 2000;118:360–364
  16. Weis E, Shah CP, Lajous M, et al. The association of host susceptibility factors and uveal melanoma: a meta-analysis. Arch Ophthalmol. 2006;124:54–60
  17. Shah CP, Weis E, Lajous M, et al. Intermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysis. Ophthalmology. 2005;112:1599–1607
  18. Shields CL, Shields JA, DePotter P, et al. Diffuse choroidal melanoma: clinical features predictive of metastasis. Arch Ophthalmol. 1996;114:956–963
  19. Shields JA, Mashayekhi A, Ra S, Shields CL. Pseudomelanomas of the posterior uveal tract. The 2006 Taylor Smith Lecture. Retina. 2005;25:767–771
  20. Prescher G, Bornfeld N, Hirche H, et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet. 1996;347:1222–1225
  21. Onken MD, Worley LA, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res. 2004;64:7205–7209
  22. Shields CL, Ganguly A, Materin MA, et al. Chromosome 3 analysis of uveal melanoma using fine needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases. The Deborah Iverson MD Lectureship. Arch Ophthalmol. 2007;125:1017–1024
  23. Robertson DM. Changing concepts in the management of choroidal melanoma. Am J Ophthalmol. 2003;136:161–170
  24. Shields CL, Shields JA, Gunduz K, et al. Radiation therapy for uveal malignant melanoma. Ophthalmic Surg Lasers. 1998;29:397–409
  25. Shields JA, Shields CL. Surgical approach to lamellar sclerouvectomy for posterior uveal melanomas. The 1986 Schoenberg Lecture. Ophthalmic Surg. 1988;19:774–780
  26. Zimmerman LE, McLean IW, Foster WD. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells?. Br J Ophthalmol. 1978;62:420–425
  27. Seigel D, Myers M, Ferris F, Steinhorn SC. Survival rates after enucleation of eyes with malignant melanoma. Am J Ophthalmol. 1979;87:751–765
  28. Straatsma BR, Fine SL, Earle JD The Collaborative Ocular Melanoma Study Research Group. Enucleation versus plaque irradiation for choroidal melanoma. Ophthalmology. 1988;95:1000–1004
  29. Straatsma BR, Diener-West M, Caldwell R, Engstrom RE Collaborative Ocular Melanoma Study Group. Mortality after deferral of treatment or no treatment for choroidal melanoma. Am J Ophthalmol. 2003;136:47–54
  30. Shields JA, Glazer LC, Mieler WF, Shields CL. Comparison of xenon arc and argon laser photocoagulation in the treatment of choroidal melanomas. Am J Ophthalmol. 1990;109:647–655
  31. Barbazetto IA, Lee TC, Rollins IS, et al. Treatment of choroidal melanoma using photodynamic therapy. Am J Ophthalmol. 2003;135:898–899
  32. Oosterhuis JA, Journee-de Korver HG, Kakebeeke-Kemme HM, Bleeker JC. Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol. 1995;113:315–321
  33. Shields CL, Shields JA, Perez N, et al. Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations. Ophthalmology. 2002;109:225–234
  34. Shields CL, Cater J, Shields JA, et al. Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma in 270 consecutive patients. Arch Ophthalmol. 2002;120:933–940
  35. Shields CL, Naseripour M, Cater J, et al. Plaque radiotherapy for large posterior uveal melanoma (>8 mm in thickness) in 354 consecutive patients. Ophthalmology. 2002;109:1838–1849
  36. Gragoudas ES, Lane AM, Munzenrider J, et al. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc. 2002;100:43–48
  37. The Collaborative Ocular Melanoma Study Group. The collaborative ocular melanoma study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 10. Am J Ophthalmol. 1998;126:779–796
  38. The Collaborative Ocular Melanoma Study Group. The COMS randomized trial of Iodine 125 brachytherapy for choroidal melanoma. III: Initial mortality findings. COMS report no. 18. Arch Ophthalmol. 2001;119:969–982
  39. The Collaborative Ocular Melanoma Study Group. Factors predictive of growth and treatment of small choroidal melanoma. COMS report no. 5. Arch Ophthalmol. 1997;115:1537–1544
  40. Diener-West M, Hawkins BS, Markowitz JA, Schachat AP. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol. 1992;110:245–250
  41. Eskelin S, Pyrhonen S, Summanen P, et al. Tumor doubling times in metastatic malignant melanoma of the uvea. Tumor progression before and after treatment. Ophthalmology. 2000;107:1443–1449
  42. Eskelin S, Kivela T. Uveal melanoma: implications of tumor doubling time. [Author's reply] Ophthalmology. 2001;108:830–831
  43. Shields CL, Fasiudden A, Mashayekhi A, Shields JA. Conjunctival nevi: clinical features and natural course in 410 consecutive patients. Arch Ophthalmol. 2004;122:167–175
  44. Shields JA, Shields CL, Mashayekhi A, et al. Primary acquired melanosis of the conjunctiva. risks for transformation into melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture. Ophthalmology. 2008;115:511–519.e2
  45. Shields CL. Conjunctival melanoma. [Editorial] Br J Ophthalmol. 2002;86:127
  46. Shields JA, Shields CL. Melanocytic tumors (of the conjunctiva). In: Atlas of eyelid and conjunctival tumors. Philadelphia: Lippincott Williams and Wilkins; 1999;p. 243–266
  47. Shields CL, Shields JA, Gunduz K, et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol. 2000;118:1497–1507
  48. Seregard S. Conjunctival melanoma. Surv Ophthalmol. 1998;42:321–350
  49. Esmaeli B, Eicher S, Popp J, et al. Sentinel lymph node biopsy for conjunctival melanoma. Ophthal Plast Reconstr Surg. 2001;17:436–442
  50. Shields JA, Shields CL. Melanocytic tumors (of the eyelid). In: Atlas of eyelid and conjunctival tumors. Philadelphia: Lippincott Williams and Wilkins; 1999;p. 75–94
  51. Shields JA, Shields CL. Primary melanocytic tumors. In: Atlas of orbital tumors. Philadelphia: Lippincott Williams and Wilkins; 1999;p. 165–172
  52. Shields JA, Shields CL, Scartozzi R. Survey of 1264 orbital tumors and pseudotumors. The 2002 Montgomery Lecture. Part 1. Ophthalmology. 2004;111:997–1008
  53. Freedman MI, Folk JC. Metastatic tumors to the eye and orbit. Patient survival and clinical characteristics. Arch Ophthalmol. 1987;105:1215–1219

☆ Support was provided by the Eye Tumor Research Foundation, Philadelphia, PA (CLS); the Macula Foundation, New York, NY (CLS); the Rosenthal Award of the Macula Society (CLS); and the Paul Kayser International Award of Merit in Retina Research, Houston TX (JAS).

PII: S0738-081X(08)00187-9

doi: 10.1016/j.clindermatol.2008.09.010

Clinics in Dermatology
Volume 27, Issue 1 , Pages 122-133 , January 2009

Article Tools

* Image Usage & Resolution